| 35.175.483 € | Execució | LABORATORIOS TILLOMED SPAIN, S.L.U (lot 64) | 35.808 € | 99,9 % | — |
| | ROCHE FARMA, S.A. (lots 1, 5, 6, 38, 58) | 1.666.091 € | 95,3 % | |
| | CIPLA EUROPE NV Sucursal en España (lot 85) | 52.780 € | 99,8 % | |
| | MACLEODS PHARMA ESPAÑA, S.L.U. (lot 80) | 14.266 € | 100 % | |
| | NOVARTIS FARMACÉUTICA, S.A. (lots 7, 8, 9, 33, 39, 40, 43, 44) | 3.993.700 € | 88,6 % | |
| | TAKEDA FARMACÉUTICA ESPAÑA, S.A. (lot 22) | 659.193 € | 98,1 % | |
| | FERRING, S.A.U. (lot 100) | 27.649 € | 99,9 % | |
| | B. BRAUN MEDICAL, S.A. (lots 101, 102, 110) | 30.037 € | 99,9 % | |
| | ACCORD HEALTHCARE, S.L.U. (lots 3,4,19,41,69,88) | 268.211 € | 99,2 % | |
| | IPSEN PHARMA, S.A. 8lots 30, 36) | 241.812 € | 99,3 % | |
| | TEVA PHARMA, S.L. (lots 12, 76, 78, 79) | 58.417 € | 99,8 % | |
| | DESERTS (lots 21, 28, 31, 73, 75, 81, 91, 92, 93, 94, 95, 104, 105, 106, 107, 108 | 0 € | 100 % | |
| | QILU PHARMA SPAIN, S.L. (lot 23) | 10.215 € | 100 % | |
| | ABBVIE SPAIN, S.L.U. (lots 57, 118) | 1.282.797 € | 96,4 % | |
| | GLAXOSMITHKLINE, S.A. (lot 10) | 57.540 € | 99,8 % | |
| | AUROVITAS SPAIN, S.A. (lots 18, 96, 97) | 21.482 € | 99,9 % | |
| | JANSSEN CILAG, S.A. (lots 25,26,27,49,50,51,59,103) | 7.310.736 € | 79,2 % | |
| | GILEAD SCIENCES, S.L. (lots 52, 119) | 129.847 € | 99,6 % | |
| | BOEHRINGER INGELHEIM ESPAÑA, S.A. (lots 45, 82, 83) | 555.388 € | 98,4 % | |
| | LABORATORIO ALDO-UNIÓN, S.L. (lot 60) | 49.088 € | 99,9 % | |
| | BAYER HISPANIA, S.L. (lots 13, 34, 48) | 257.324 € | 99,3 % | |
| | KERN PHARMA, S.L. (lots 35, 77) | 76.967 € | 99,8 % | |
| | VISO FARMACÉUTICA, S.L.U (lots 70, 74) | 29.878 € | 99,9 % | |
| | FRESENIUS KABI ESPAÑA, S.A.U. (lots 20, 109) | 50.787 € | 99,9 % | |
| | MERCK SHARP DOHME DE ESPAÑA, S.A. (lots 2,63,65,66,67,68,71,72,111,112,113,114,115) | 6.572.725 € | 81,3 % | |
| | SANDOZ FARMACÉUTICA, S.A. (lot 37) | 10.128 € | 100 % | |
| | SANOFI - AVENTIS, S.A. (lot 11) | 91.907 € | 99,7 % | |
| | AMGEN, S.A. (lots 24,98,99) | 585.406 € | 98,3 % | |
| | SWEDISH ORPHAN BIOVITRUM, S.L. (lot 14) | 49.874 € | 99,9 % | |
| | LILLY, S.A. (lots 29, 61, 62) | 800.989 € | 97,7 % | |
| | LABORATORIOS NORMON, S.A. (lots 86, 87) | 18.188 € | 99,9 % | |
| | CSL BEHRING, S.A. (lots 53, 54, 55, 56) | 455.353 € | 98,7 % | |
| | SUN PHARMA LABORATORIOS, S.L.U. (lot 90) | 78.759 € | 99,8 % | |
| | BIOGEN SPAIN, S.L. (lot 32) | 55.831 € | 99,8 % | |
| | ALTAN PHARMACEUTICALS, S.A.U. (lots 116, 117) | 36.837 € | 99,9 % | |
| | PFIZER, S.L.U. (lots 15, 16, 17, 46, 47, 84) | 219.000 € | 99,4 % | |
| | REDDY PHARMA IBERIA, S.A.U. (lot 89) | 88.784 € | 99,7 % | |
Licit